ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 97 filers reported holding ARATANA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 20.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $43,000 | +43.3% | 8,380 | 0.0% | 0.00% | – |
| Q1 2019 | $30,000 | -41.2% | 8,380 | -0.0% | 0.00% | – |
| Q4 2018 | $51,000 | +37.8% | 8,382 | +31.4% | 0.00% | – |
| Q3 2018 | $37,000 | +208.3% | 6,380 | +127.9% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | 0.0% | 2,800 | +23.6% | 0.00% | – |
| Q4 2017 | $12,000 | -14.3% | 2,265 | 0.0% | 0.00% | – |
| Q3 2017 | $14,000 | +100.0% | 2,265 | +134.7% | 0.00% | – |
| Q2 2017 | $7,000 | +40.0% | 965 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | -64.3% | 965 | -50.0% | 0.00% | – |
| Q4 2016 | $14,000 | -22.2% | 1,930 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | +50.0% | 1,930 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | +9.1% | 1,930 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | +1000.0% | 1,930 | +869.8% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 199 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $1,219,000 | 11.21% |
| Broadfin Capital, LLC | 3,428,865 | $19,133,000 | 1.18% |
| MPM ASSET MANAGEMENT LLC | 1,117,875 | $6,238,000 | 1.11% |
| AlpInvest Partners B.V. | 100,001 | $558,000 | 0.93% |
| First Light Asset Management, LLC | 395,043 | $2,204,000 | 0.92% |
| Westend Capital Management, LLC | 89,780 | $501,000 | 0.69% |
| Grandeur Peak Global Advisors, LLC | 460,675 | $2,571,000 | 0.53% |
| AWM Investment Company, Inc. | 467,507 | $2,609,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 111,705 | $623,000 | 0.27% |
| Sio Capital Management, LLC | 97,376 | $543,000 | 0.24% |